India's Drug Regulator Issues Alert on Stolen Medicines from Novo Nordisk

Strategic Insights -

The Drugs Controller General of India (DCGI) has issued a notice regarding the theft of several batches of injectable medicines belonging to Novo Nordisk during transit. The stolen products are temperature-sensitive, requiring storage at 2°C to 8°C, and improper storage could compromise their quality and safety. The products include Insulin degludec/Insulin aspart, Insulin aspart, Semaglutide Injection 0.5 mg, Semaglutide Injection 0.25 mg, and Semaglutide Injection 1 mg. The DCGI has cautioned doctors and healthcare professionals to exercise caution while prescribing these products and to educate patients about reporting any adverse drug reactions.

Key Takeaways:

  • The theft of Novo Nordisk's injectable medicines has been reported to the DCGI, with several batches stolen during transit from Bhiwandi to distribution routes covering Nagpur, Raipur, Cuttack, and Kolkata.
  • The stolen products are temperature-sensitive and must be stored at 2°C to 8°C to maintain their quality and safety.
  • Improper storage could compromise the quality and safety of these medicines, posing serious risks to patient safety.
  • The products under consideration include Insulin degludec/Insulin aspart, Insulin aspart, Semaglutide Injection 0.5 mg, Semaglutide Injection 0.25 mg, and Semaglutide Injection 1 mg.
  • Doctors and healthcare professionals have been advised to exercise caution while prescribing these products and to educate patients about reporting any adverse drug reactions (ADRs).
  • Patients and consumers have been urged to procure these medicines only from authorized sources with a valid invoice.

Statistics:

  • 6 batches of Novo Nordisk's injectable medicines have been stolen during transit.
  • 5 of the stolen products require storage at 2°C to 8°C.
  • 1 of the stolen products is Insulin degludec/Insulin aspart.
  • 2 of the stolen products are Insulin aspart.
  • 3 of the stolen products are Semaglutide Injection.
  • 16 batches of Novo Nordisk's injectable medicines have been distributed to 4 states.

Sources:

  • Drugs Controller General of India (DCGI)
  • Central Drugs Standard Control Organization (CDSCO)
  • Novo Nordisk Ltd.